Skip to main content
. 2018 Jul 7;24(10):2093–2103. doi: 10.1093/ibd/izy222

TABLE 3:

Health Care Utilization and Costs

No Chronic Opioid Therapy; Enrollment for 2+ y (n = 76,584) Chronic Opioid Therapy for 1–3 y; Enrollment ≥4 y (n = 2371) Persistent Chronic Opioid Therapy ≥4 y (n = 132) P
Health care utilization
IBD hospitalizations, %
 0 74.4 36.9 15.2 <0.001
 1–2 15.5 42 43.7
 3–4 4.7 10.4 16.1
 5+ 5.4 10.6 25
≥1 IBD surgeries 7.8 26.4 46.2 <0.001
Outpatient visits, mean 12.3 16.3 26.4 <0.001
≥1 ED visits 48.5 88.1 96.2 <0.001
Polypharmacy,a mean 3.9 4.2 5.9 <0.001
No. prescriptions, %
 0–4 65 61.7 28
 5+ 35 38.3 72 <0.001
Health care costs
High-cost patients,b % 9.2 13.9 28.8 <0.001
Total costs per year (SD), $ 20,473 (40,105) 28,139 (30,342) 44,766 (42,823) <0.001
Hospitalization cost (SD), $ 6351 (7041) 7028 (7996) 5284 (3597) <0.001

aExcluding IBD medications.

bHigh-cost patients defined as annual health care costs >$50,000.